{"count": 2, "results": [{"_id": "2163421", "pmid": 2163421, "title": "Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.", "journal": "J Hypertens", "authors": ["Fletcher AE", "Bulpitt CJ", "Hawkins CM", "Havinga TK", "ten Berge BS", "May JF", "Schuurman FH", "van der Veur E", "Wesseling H"], "date": "1990-05-01T00:00:00Z", "doi": "10.1097/00004872-199005000-00011", "meta_date_publication": "1990 May", "meta_volume": "8", "meta_issue": "5", "meta_pages": "463-6", "score": 50066.01, "text_hl": "A randomized double-blind study lasting 2 months was performed with either 25 mg @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@ twice a day or 50 mg @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ once a day in 125 @SPECIES_9606 @@@patients@@@ with established @<m>DISEASE_Hypertension_Diastolic_Resistance_to</m> @DISEASE_MESH:C563897 @@@diastolic hypertension@@@ (diastolic blood pressure greater than 95 mmHg) identified during a population screening programme of subjects aged less than 65 years. ", "citations": {"NLM": "Fletcher AE, Bulpitt CJ, Hawkins CM, Havinga TK, ten Berge BS, May JF, Schuurman FH, van der Veur E, Wesseling H. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens. 1990 May;8(5):463-6. PMID: 2163421", "BibTeX": "@article{2163421, title={Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.}, author={Fletcher AE and Bulpitt CJ and Hawkins CM and Havinga TK and ten Berge BS and May JF and Schuurman FH and van der Veur E and Wesseling H}, journal={J Hypertens}, volume={8}, number={5}, pages={463-6}}"}}, {"_id": "19008724", "pmid": 19008724, "title": "Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women.", "journal": "J Hypertens", "authors": ["Pöyhönen-Alho MK", "Manhem K", "Katzman P", "Kibarskis A", "Antikainen RL", "Erkkola RU", "Tuomilehto JO", "Ebeling PE", "Kaaja RJ"], "date": "2008-12-01T00:00:00Z", "doi": "10.1097/HJH.0b013e328311cf37", "meta_date_publication": "2008 Dec", "meta_volume": "26", "meta_issue": "12", "meta_pages": "2445-9", "score": 50052.844, "text_hl": "We compared the effect of two sympatholytic antihypertensive drug treatments, the centrally acting @GENE_NISCH @GENE_11188 @@@imidazoline receptor-1@@@ agonist @CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidine@@@ and peripherally acting beta-blocking agent @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on sensitive @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ markers in @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@ postmenopausal @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Hypertension_Diastolic_Resistance_to</m> @DISEASE_MESH:C563897 @@@diastolic hypertension@@@. ", "citations": {"NLM": "Pöyhönen-Alho MK, Manhem K, Katzman P, Kibarskis A, Antikainen RL, Erkkola RU, Tuomilehto JO, Ebeling PE, Kaaja RJ. Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens. 2008 Dec;26(12):2445-9. PMID: 19008724", "BibTeX": "@article{19008724, title={Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women.}, author={Pöyhönen-Alho MK and Manhem K and Katzman P and Kibarskis A and Antikainen RL and Erkkola RU and Tuomilehto JO and Ebeling PE and Kaaja RJ}, journal={J Hypertens}, volume={26}, number={12}, pages={2445-9}}"}}]}